Insufficient scRNA-seq data for expression of NUDT13 at single-cell level.
Insufficient scRNA-seq data for expression of NUDT13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 275.79 | 245 / 245 | 98% | 3.34 | 494 / 502 |
esophagus | 99% | 215.55 | 1437 / 1445 | 98% | 3.80 | 180 / 183 |
breast | 100% | 239.74 | 459 / 459 | 98% | 3.92 | 1091 / 1118 |
pancreas | 100% | 200.55 | 327 / 328 | 98% | 3.75 | 174 / 178 |
liver | 100% | 446.59 | 226 / 226 | 97% | 4.79 | 394 / 406 |
intestine | 100% | 299.88 | 966 / 966 | 97% | 3.32 | 510 / 527 |
thymus | 100% | 264.70 | 653 / 653 | 96% | 2.92 | 580 / 605 |
kidney | 100% | 316.56 | 89 / 89 | 95% | 4.78 | 858 / 901 |
stomach | 100% | 262.84 | 358 / 359 | 95% | 3.49 | 273 / 286 |
brain | 98% | 124.98 | 2583 / 2642 | 97% | 3.32 | 686 / 705 |
bladder | 100% | 306.29 | 21 / 21 | 95% | 3.53 | 477 / 504 |
adrenal gland | 100% | 343.45 | 258 / 258 | 92% | 2.73 | 211 / 230 |
lung | 97% | 211.80 | 560 / 578 | 94% | 3.56 | 1086 / 1155 |
ovary | 100% | 227.28 | 180 / 180 | 91% | 2.58 | 390 / 430 |
skin | 100% | 244.15 | 1808 / 1809 | 87% | 2.86 | 411 / 472 |
uterus | 100% | 240.48 | 170 / 170 | 84% | 2.36 | 385 / 459 |
spleen | 100% | 331.23 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.37 | 1 / 1 |
muscle | 100% | 314.59 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 212.39 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 207.38 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 258.81 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 3.51 | 74 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 1.64 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 76% | 1.65 | 22 / 29 |
peripheral blood | 60% | 102.79 | 553 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006734 | Biological process | NADH metabolic process |
GO_0015949 | Biological process | nucleobase-containing small molecule interconversion |
GO_0006742 | Biological process | NADP catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0016462 | Molecular function | pyrophosphatase activity |
GO_0000210 | Molecular function | NAD+ diphosphatase activity |
GO_0035529 | Molecular function | NADH pyrophosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NUDT13 |
Protein name | NUDT13 protein Nudix (Nucleoside diphosphate linked moiety X)-type motif 13, isoform CRA_c (Nudix hydrolase 13) NAD(+) diphosphatase (EC 3.6.1.22) NAD(P)H pyrophosphatase NUDT13, mitochondrial (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 13) (Nudix motif 13) (Protein KiSS-16) |
Synonyms | hCG_19272 |
Description | FUNCTION: NAD(P)H pyrophosphatase that hydrolyzes NADH into NMNH and AMP, and NADPH into NMNH and 2',5'-ADP. Has a marked preference for the reduced pyridine nucleotides. Does not show activity toward NAD-capped RNAs; the NAD-cap is an atypical cap present at the 5'-end of some RNAs. . |
Accessions | ENST00000617744.4 A0A087X1G4 Q4G134 ENST00000372997.3 [Q86X67-4] ENST00000349051.9 [Q86X67-2] Q86X67 ENST00000537969.5 B4E059 ENST00000357321.9 [Q86X67-1] ENST00000544879.5 [Q86X67-3] |